This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
December 08, 2020
Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19
December 07, 2020
Oncopeptides will host a webcast on Wednesday, December 9[th] at 14:00 (CET) to provide an update regarding data presented at the ASH annual meeting
December 07, 2020
Orexo Enters Exclusive License and Supply Agreement with Accord Healthcare for ZUBSOLV[® ]in Europe
December 06, 2020
Oncopeptides presents new data from phase 2 ANCHOR combination study in multiple myeloma at American Society of Hematology meeting ASH
December 02, 2020
Targovax ASA: Invitation to online presentation at 10:00 CET 2 December
December 01, 2020
Nordic Nanovector completes patient enrolment into Phase 1 trial of Betalutin[®] in Diffuse Large B Cell Lymphoma
December 01, 2020
Targovax announces impressive objective responses as well as effects on non-injected lesions in ONCOS-102 trial in anti-PD1 refractory melanoma patients
November 30, 2020
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
November 30, 2020
Strong CERAMENT data published in Science Advances
November 30, 2020
Aprea Therapeutics Receives FDA Fast Track Designation for Eprenetapopt in the Treatment of TP53 Mutant Acute Myeloid Leukemia (AML)